Kevin DeGeeterManaging Director, Healthcare Research at Oppenheimer & Co. Inc.
Kevin DeGeeter is Managing Director and Senior Analyst covering Biotechnology and Diagnostics. Prior to re-joining Oppenheimer, Kevin was Senior Analyst covering Biotechnology at Ladenburg Thalmann, and focused on oncology, infectious diseases, cell therapy and molecular diagnostics. He has 20 years of buy-side and sell-side research experience including senior analyst positions with J.P Morgan, Paine Webber, Natexis Bleichroeder and Manning & Napier Advisors. He was previously at Oppenheimer & Co. from 2007-2009, also as a Senior Analyst covering Biotechnology. He received a BA. from Colgate University.